Iran's Leap into the Future; an Exploration of Tissue Engineering Companies: Review Article
- Narges Fereydouni 1,2,3, Mohammad Ebrahim Astaneh 1,3,4, Morteza Seifalah-Zade 1,2,3, Alireza Hashemzadeh 5
- Narges Fereydouni 1,2,3, Mohammad Ebrahim Astaneh 1,3,4, Morteza Seifalah-Zade 1,2,3
- 1Department of Tissue Engineering, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
- 2Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
- 3Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran.
- 4Department of Anatomical Sciences, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
- 5Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- 0Department of Tissue Engineering, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This review details Iran
Area Of Science
- Regenerative Medicine
- Biotechnology
- Biomaterials Science
Background
- Comprehensive review of Iran's tissue engineering landscape up to 2024.
- Identifies 56 entities: 29 commercial, 17 service, 10 research.
- Majority (64%) based in Tehran, many established post-2004.
Purpose Of The Study
- To provide a detailed overview of Iran's tissue engineering sector development.
- To identify key players and their contributions.
- To highlight future prospects and research directions.
Main Methods
- Extensive search of official websites for commercial, service, and research entities.
- Descriptive methodology with in-depth data analysis.
- Theoretical discussion of findings and future implications.
Main Results
- Biomaterials dominate product portfolios (50%) and research focus (38%).
- Cell-based products represent 12% of offerings but 38% of research, indicating high growth potential.
- Significant concentration of entities in Tehran.
Conclusions
- Iran's tissue engineering sector shows promise, particularly in cell-based therapies.
- Need for enhanced regulatory frameworks to support commercialization.
- Identified research gaps and proposed future study directions.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

